Comparison of Up-to-Date Status Between Study Groups, at Baseline and at Follow-up, According to Subgroup Analysis Among Women Reached by Telephone at Least Once, Still Eligible, and Willing to Participate
Unadjusted Comparison | Adjusted Comparison* | |||||
---|---|---|---|---|---|---|
Screening | PCM No. (%) Up-to-Date | AMOP No. (%) Up-to-Date | OR (95% CI) | P Value | OR (95% CI) | P Value |
PCM = prevention care management; AMOP = Affinity Mammography Outreach Program (the comparison group); OR = odds ratio; CI = confidence interval. | ||||||
* Baseline breast and cervical comparisons are adjusted for age (40 to 49 years, 50 years and older); there is no adjusted colorectal baseline comparison because this analysis included only women aged 50 years and older. Follow-up comparisons are adjusted for age (breast and cervical) and for baseline screening status (all 3 screenings). | ||||||
†P ≤.05. | ||||||
‡ Smaller n values for colorectal screening reflect the subset of the study population who were eligible for colorectal cancer screening (ie, aged 50 years and older). | ||||||
Breast | (n=268) | (n=271) | ||||
Baseline | 111 (41.4) | 133 (49.1) | 0.73 (0.51–1.05) | .07 | 0.69 (0.46–1.04) | .08 |
Follow-up | 192 (71.6) | 193 (71.2) | 1.02 (0.69–1.51) | .91 | 1.39 (0.88–2.20) | .16 |
Cervical | (n=268) | (n=271) | ||||
Baseline | 155 (57.8) | 160 (59.0) | 0.95 (0.67–1.36) | .78 | 0.95 (0.68–1.35) | .79 |
Follow-up | 207 (77.2) | 195 (72.0) | 1.32 (0.88–1.99) | .16 | 1.86† (1.08–3.21) | .03 |
Colorectal‡ | (n=152) | (n=160) | ||||
Baseline | 25 (16.4) | 27 (16.9) | 0.97 (0.51–1.84) | .92 | – | – |
Follow-up | 52 (34.2) | 44 (27.5) | 1.37 (0.82–2.29) | .20 | 1.84 (0.95–3.58) | .07 |